Fig. 7
From: EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma
Association of EXOSC5 expression with immune therapy outcome. A-B: Scatter plots depicting the correlations between EXOSC5 expression and TMB (A) and MSI (B). C: Scatter plot showing the relationship between EXOSC5 and PD1 expression. D: EXOSC5 mRNA levels in anti-PD1-treated samples from the GSE120644 dataset were compared between responders and nonresponders. E: EXOSC5 mRNA levels in anti-PD1-treated samples compared between PR/CR patients and PD/SD patients (PMID: 37024582). F-G: EXOSC5 expression levels were correlated with overall survival (OS) and progression-free survival (PFS) in anti-PD1-treated patients. H: Heatmap showing drug sensitivity in EXOSC5-low vs. EXOSC5-high samples, with color intensity indicating drug sensitivity. I: Correlations of drug sensitivity scores with EXOSC5 RNA expression